Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Aug 2022 10:38

RNS Number : 6164U
CATCo Reinsurance Opps Fund Ltd
02 August 2022
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

CATCo Reinsurance Opportunities Fund Ltd

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Weiss Asset Management LP

City and country of registered office (if applicable)

Wilmington, Delaware, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

Brookdale International Partners, L.P., Brookdale Global Opportunity Fund

City and country of registered office (if applicable)

Brookdale International Partners, L.P.: Albany, NY, USA

Brookdale Global Opportunity Fund: Grand Cayman, Cayman Islands

5. Date on which the threshold was crossed or reachedvi:

Jul-29-2022

6. Date on which issuer notified (DD/MM/YYYY):

Aug-1-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

27.59%

0%

27.59%

2,325,507

Position of previous notification (if

applicable)

28.42%

0%

28.42%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

BMG1961Q4075

361,860

15.56%

BMG1961Q5064

279,719

12.03%

SUBTOTAL 8. A

641,579

27.59%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Weiss Asset Management LP

Brookdale International Partners, L.P.

17.76%

0%

17.76%

Weiss Asset Management LP

Brookdale Global Opportunity Fund

9.83%

0%

9.83%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Weiss Asset Management LP is the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International Partners, L.P.

 

Note: This notification is being furnished to the issuer pursuant to Article 12.3 of the issuer's Articles of Association adopted 29 January 2015.

 

 

Place of completion

Boston, USA

Date of completion

Aug-1-2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUUOKRUNUWRRR
Date   Source Headline
16th May 200612:41 pmRNSEPT Disclosure
16th May 200612:17 pmRNSEPT Disclosure
16th May 200611:42 amRNSEPT Disclosure
16th May 200610:45 amRNSRule 8.3- Cambridge Antibody
15th May 20062:56 pmRNSRule 8.3- Cambridge Antibody
15th May 20067:03 amRNSOffer for Cambridge Antibody
15th May 20067:03 amRNSStatement
13th Apr 200610:03 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 200610:00 amRNSBlocklisting Interim Review
13th Apr 20069:52 amRNSBlocklisting Interim Review
7th Apr 20061:12 pmRNSHolding(s) in Company
6th Mar 200611:03 amRNS20-F filing
3rd Mar 200611:07 amRNSHolding(s) in Company
9th Feb 20065:23 pmRNSDirector/PDMR Shareholding
9th Feb 200610:49 amRNSDirector/PDMR Shareholding
6th Feb 20067:01 amRNS1st Quarter Results
3rd Feb 20063:30 pmRNSAGM Statement
3rd Feb 20061:00 pmRNSRe: Q1 2006 Statement
31st Jan 20069:22 amRNSNotice of Results
25th Jan 20063:01 pmRNSSales update
3rd Jan 200610:18 amRNSAdditional Listing
3rd Jan 20067:00 amRNSDirector/PDMR Shareholding
23rd Dec 200510:00 amRNSCAT Annual Report sent to FSA
20th Dec 20053:32 pmRNSHolding(s) in Company
20th Dec 20053:29 pmRNSDirector/PDMR Shareholding
5th Dec 200511:23 amRNSDirector/PDMR Shareholding
1st Dec 20053:36 pmRNSDirector/PDMR Shareholding
28th Nov 20054:11 pmRNSDirector/PDMR Shareholding
28th Nov 20057:02 amRNSFinal Results
25th Nov 20053:33 pmRNSDirector/PDMR Shareholding
1st Nov 20057:01 amRNSProduct Candidate Acquisition
27th Oct 20053:46 pmRNSNotice of Results
26th Oct 20057:01 amRNSCAT & ABBOTT AGREE ROYALTIES
12th Oct 20055:12 pmRNSHolding(s) in Company
5th Oct 20053:30 pmRNSResearch Update
30th Sep 20052:55 pmRNSBlocklisting Interim Review
30th Sep 20052:52 pmRNSBlocklisting Interim Review
30th Sep 20052:46 pmRNSBlocklisting Interim Review
23rd Sep 20054:34 pmRNSHolding(s) in Company
15th Sep 20054:19 pmRNSDirector/PDMR Shareholding
12th Sep 20057:01 amRNSDirectorate Change
12th Sep 20057:01 amRNS3rd Quarter Results
19th Aug 20059:39 amRNSHolding(s) in Company
18th Aug 200510:01 amRNSHolding(s) in Company
15th Aug 200510:17 amRNSNotice of Results
23rd Jun 20057:01 amRNSCAT-354 Clinical Update
1st Jun 20055:20 pmRNSHolding(s) in Company
20th May 20058:00 amRNSUpdate re Abbott
19th May 200512:31 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.